• About us
• Contact

Advertisement

Organisation › Details

BiomX Ltd.

BiomX is a microbiome drug discovery company developing customized phage therapies that seek and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. We discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. The Company’s platforms use computational and synthetic biology and cutting-edge research from Profs. Rotem Sorek, Ph.D., Eran Elinav, M.D., Ph.D., and Eran Segal, Ph.D., of The Weizmann Institute of Science; and Professor Timothy K. Lu, M.D., Ph.D., of The Massachusetts Institute of Technology. Investors in the Company include OrbiMed Israel Incubator LP, Johnson & Johnson Development Corporation Inc., Takeda Ventures, Inc., Seventure Partners, Mirae Asset, and SBI. *

 

	Start	2017-05-15 renamed before
	Group	BiomX (Group)
	Predecessor	MBcure (IL)
	Industry	microbiomics
	Industry 2	phage therapy
	Person	Solomon, Jonathan (BiomX 201705 CEO before Proclara/NeuroPhage 201403 CEO before Israeli military)
	Region	Israel_oo
	Country	Israel
	Street	7 Pinhas Sapir Street Floor 2
	City	7414002 Ness Ziona
	Tel	+972-72-3942377
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		�About Section� taken from web site of organisation on 08.03.
		Record changed: 2023-07-10

Advertisement

More documents for BiomX (Group)

• [1] BiomX Inc.. (9/2/20). "Press Release: BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease". Ness Ziona....
• [2] BiomX Ltd.. (10/28/19). "Press Release: Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.". New York, NY & Ness Ziona....
• [3] BiomX Ltd.. (10/23/19). "Press Release: Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona....
• [4] BiomX Ltd.. (10/15/19). "Press Release: BiomX Appoints Merav Bassan as Chief Development Officer". Ness Ziona....
• [5] BiomX Ltd.. (10/14/19). "Press Release: Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona....
• [6] BiomX Ltd.. (7/17/19). "Press Release: Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona....
• [7] BiomX Ltd.. (2/20/19). "Press Release: BiomX Raises $32 Million in Series B Financing. Proceeds Will Be Used Primarily to Advance Leading IBD and Acne Programs to the Clinic". Ness Ziona....
• [8] BiomX Ltd.. (12/12/18). "Press Release: BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD". Ness Ziona....
• [9] BiomX Ltd.. (12/11/18). "Press Release: BiomX Appoints Sailaja Puttagunta as Chief Medical Officer. BiomX Setting Up Operations to Enter the Clinic in IBD and Additional Indications". Ness Ziona....
• [10] BiomX Ltd.. (1/29/18). "Press Release: BiomX Licenses Novel Bacterial Targets for the Treatment of IBD". Ness Ziona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.